GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

ImpediMed IPD.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.00

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

ImpediMed — daily ASX:IPD

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View ImpediMed on TradingView ↗
Market value
A$6.1m
Last close × shares
Volume
247.8k
Shares, 9 Nov 2026

About ImpediMed

Its shares trade on ASX under the ticker IPD.AX. It has been listed since 24 October 2007. In the fiscal year to 30 June 2026, it reported revenue of A$14.6m and a net loss of A$24.9m. At that date it held total assets of A$34.7m and shareholders' equity of A$10.2m.

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland. The company went IPO on 2007-10-24. The principal activities of the Company consist of the development, manufacture and sale of bioimpedance instruments and consumables, and the sale of electronic test and measurement devices. The firm's operating segments include Medical, and Test & Measurement. The Medical segment is a supplier of non-invasive medical devices to over two underserved markets: aiding in the subclinical assessment of individuals at risk of secondary lymphedema, and the monitoring of body composition and hydration. The medical cash-generating unit (CGU) is the core business of the Company. The Test & Measurement segment is a supplier of power precision testing and measuring equipment (T&M). The firm's geographical locations include Australia/rest of world (ROW) and North America.

Figures and description from our data supplier, not checked against the company's own report.

More about ImpediMed →

Latest on ImpediMed

Our reporting

We have not reported on ImpediMed yet.

Next results

25 Feb 2027

Due on 25 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is ImpediMed's ticker?

ImpediMed trades as IPD.AX on ASX, under ISIN AU000000IPD8.

What was ImpediMed's last closing price?

0.00 on 9 Nov 2026. The figure is in AUD and is never converted.

When does ImpediMed next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.